The early examination of combined serum and imaging data under flexible fiberoptic bronchoscopy as a novel predictor for refractory Mycoplasma pneumoniae pneumonia diagnosis
Open Access
- 1 December 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (50) , e9364
Abstract
The treatment role of flexible bronchoscopy (FOB) for pediatric refractory Mycoplasma pneumoniae pneumonia (RMPP) has been well documented. Besides, the application indication of FOB is also studied in patients with general MPP (GMPP), especially in those with large pulmonary lesions. This study was designed to examine the diagnostic value of bronchoscopic features for RMPP. The FOB and bronchoalveolar lavage (BAL) were adopted for pediatric patients who showed clinical and radiograph indications. On the basis of the final diagnosis on discharge, patients were divided into general and refractory MPP groups. The clinical, laboratory, and bronchoscopic imaging features were retrospectively investigated between these 2 groups. From June 2012 to May 2014, a total of 62 RMPP and 101 GMPP patients were treated with therapeutic bronchoscopy. The comparison analysis showed that the CRP, HBDH, LDH were significantly different between RMPP and GMPP groups (all P < .001). In the bronchoscopic imaging, the mucus plug was significantly more commonly seen in the RMPP group (P < .001). Receiver operating characteristic (ROC) analysis revealed that the combined serum, clinical, and FOB imaging data possessed greater specificity and sensitivity than serum and clinical data alone. Our data suggest that the combined serum, clinical, and bronchoscopic imaging data might serve as a promising predictor for early RMPP diagnosis for pediatric patients with large pulmonary lesions.Keywords
This publication has 40 references indexed in Scilit:
- Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in childrenPediatric Pulmonology, 2013
- Ciliary ultrastructural abnormalities in Mycoplasma pneumoniae pneumonia in 22 pediatric patientsEuropean Journal of Pediatrics, 2011
- Molecular Mechanisms of Macrolide Resistance in Clinical Isolates of Mycoplasma pneumoniae from ChinaAntimicrobial Agents and Chemotherapy, 2009
- Clinical Evaluation of Macrolide-Resistant Mycoplasma pneumoniaeAntimicrobial Agents and Chemotherapy, 2006
- Necrotizing Pneumonitis Caused by Mycoplasma pneumoniae in Pediatric PatientsThe Pediatric Infectious Disease Journal, 2004
- Comparison and Evaluation of Real-Time PCR, Real-Time Nucleic Acid Sequence-Based Amplification, Conventional PCR, and Serology for Diagnosis of Mycoplasma pneumoniaeJournal of Clinical Microbiology, 2003
- Fulminant Mycoplasma pneumoniae Pneumonia.Internal Medicine, 2001
- Severe Acute Lung Injury Caused byMycoplasma pneumoniae: Potential Role for Steroid Pulses in TreatmentClinical Infectious Diseases, 2000
- Evaluation of Meridian ImmunoCard Mycoplasma Test for the Detection of Mycoplasma Pneumoniae-specific IgM in Paediatric PatientsScandinavian Journal of Infectious Diseases, 1998
- Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mu-capture ELISA and indirect immunofluorescence.Journal of Clinical Pathology, 1990